<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="134361">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01749579</url>
  </required_header>
  <id_info>
    <org_study_id>130-2640</org_study_id>
    <nct_id>NCT01749579</nct_id>
  </id_info>
  <brief_title>Comparison of Propofol-fentanyl and Midazolam-fentanyl for Conscious Sedation</brief_title>
  <official_title>Comparison of Propofol-fentanyl and Midazolam-fentanyl for Conscious Sedation in Painful Procedures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tehran University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tehran University of Medical Sciences</source>
  <oversight_info>
    <authority>Iran: Ethics Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sixty patients who refer to the emergency ward and need any painful procedure in the ward
      are randomized into 2 groups. One group is sedated before the procedure using
      propofol-fentanyl and the other with midazolam-fentanyl, with the same depth of sedation.
      The two groups will be compared regarding recovery time and other parameters described
      below.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2012</start_date>
  <completion_date type="Anticipated">February 2013</completion_date>
  <primary_completion_date type="Anticipated">January 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Recovery time</measure>
    <time_frame>Within one hour after sedation</time_frame>
    <safety_issue>No</safety_issue>
    <description>Length of time before complete recovery from sedation is achieved</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patients' Pain perception</measure>
    <time_frame>Within one hour after sedation</time_frame>
    <safety_issue>No</safety_issue>
    <description>Pain perception as measured by verbal numeric rating scale</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Blood pressure</measure>
    <time_frame>Within one hour after sedation</time_frame>
    <safety_issue>Yes</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>Oxygen saturation</measure>
    <time_frame>Within one hour after sedation</time_frame>
    <safety_issue>Yes</safety_issue>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Emergencies</condition>
  <arm_group>
    <arm_group_label>Propofol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The patients will receive propofol for sedation in addition to fentanyl</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Midazolam</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The patients will receive midazolam for sedation in addition to fentanyl</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>Propofol 1 mg/kg bolus then 500 microg/kg every 2 minutes until sedation level equivalent to Ramsey 3</description>
    <arm_group_label>Propofol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Midazolam</intervention_name>
    <description>Midazolam 0.03 mg/Kg stat and then the same dose repeated every 2 minutes until a sedation level of Ramsey 3 is achieved.</description>
    <arm_group_label>Midazolam</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl</intervention_name>
    <description>Fentanyl 2 microg/kg intravenous stat and every 2 minutes until the end of procedure</description>
    <arm_group_label>Propofol</arm_group_label>
    <arm_group_label>Midazolam</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age more than 18

          -  candidate for a painful procedure

          -  negative past history of a serious medical condition

          -  ASA score 0 and 1

        Exclusion Criteria:

          -  deep sedation making the patient unable to answer the questions

          -  pregnancy

          -  allergy to drugs

          -  hemodynamic instability

          -  failure to consent
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mohammad Jalili, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Tehran University of Medical Sciences</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mohammad Jalili, MD</last_name>
    <phone>+98(912)5483998</phone>
    <email>mjalili@tums.ac.ir</email>
  </overall_contact>
  <location>
    <facility>
      <name>Imam Khomeini Hospital</name>
      <address>
        <city>Tehran</city>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>December 2012</verification_date>
  <lastchanged_date>December 11, 2012</lastchanged_date>
  <firstreceived_date>December 6, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>propofol</keyword>
  <keyword>midazolam</keyword>
  <keyword>duration of recovery</keyword>
  <keyword>emergency procedure</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Emergencies</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Midazolam</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Propofol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
